Longitudinal Changes in Resting-State Cerebral Activity in Patients with First-Episode Schizophrenia: A 1-Year Follow-up Functional MR Imaging Study.

Purpose To determine whether the brain functional abnormalities of drug-naive first-episode schizophrenia are reduced after 1 year of undergoing antipsychotic treatment and whether pretreatment resting-state functional magnetic resonance (MR) imaging parameters are associated with longitudinal changes in clinical symptoms. Materials and Methods This prospective study was approved by the local ethical committee, and written informed consent was obtained from all participants. Twenty antipsychotic-naive first-episode patients with schizophrenia and 16 healthy individuals were recruited and underwent resting-state functional MR imaging at baseline and again at 1-year follow-up, by which time significant clinical improvement was seen. The amplitude of low-frequency fluctuation (ALFF) and seed-based functional connectivity (FC) were analyzed with analysis of covariance. Results The amount of ALFF in the right inferior parietal lobule (IPL) and orbitofrontal cortex (OFC) and the amount of FC between the bilateral IPLs significantly increased over the follow-up period, and the amount of ALFF in the right occipital gyrus was reduced (P < .050, AlphaSim corrected [ http://afni.nimh.nih.gov/pub/dist/doc/manual/AlphaSim.pdf ]), returning toward normal levels. Furthermore, the degree of alteration in ALFF values in the right OFC (P = .037) and occipital gyrus (P = .002) at baseline was significantly correlated with the magnitude of the normalization in those regions at 1-year follow-up. In contrast, abnormalities of ALFF in the bilateral thalamus, ventral medial prefrontal cortex, precuneus, and right amygdala and of FC between the right OFC and the dorsal medial prefrontal cortex at baseline did not improve in patients at 1-year follow-up. Conclusion These findings show that some, but not all, neurophysiologic alterations that occur during the acute phase of schizophrenia are normalized in the context of clinical improvement and suggest therapeutic implications for exploration of which alterations in regional and network-level brain function evolve over time in patients with schizophrenia and which reflect persistent pathologic traits. Online supplemental material is available for this article.

[1]  N. Mashal,et al.  The role of the precuneus in metaphor comprehension: evidence from an fMRI study in people with schizophrenia and healthy participants , 2014, Front. Hum. Neurosci..

[2]  John A. Sweeney,et al.  Altered transfer of visual motion information to parietal association cortex in untreated first-episode psychosis: Implications for pursuit eye tracking , 2011, Psychiatry Research: Neuroimaging.

[3]  N. Andreasen,et al.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies , 2013, Neuroscience & Biobehavioral Reviews.

[4]  Anvi Vora,et al.  Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. , 2013, The American journal of psychiatry.

[5]  J. Sweeney,et al.  Impact of antipsychotic treatment on attention and motor learning systems in first-episode schizophrenia. , 2015, Schizophrenia bulletin.

[6]  Antipsychotic drug effects in schizophrenia: a review of longitudinal FMRI investigations and neural interpretations. , 2013, Current medicinal chemistry.

[7]  Wei Deng,et al.  Anatomical and functional brain abnormalities in drug-naive first-episode schizophrenia. , 2013, The American journal of psychiatry.

[8]  Yufeng Zang,et al.  DPARSF: A MATLAB Toolbox for “Pipeline” Data Analysis of Resting-State fMRI , 2010 .

[9]  J. Gabrieli,et al.  Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia , 2009, Proceedings of the National Academy of Sciences.

[10]  M. Fox,et al.  Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging , 2007, Nature Reviews Neuroscience.

[11]  Yufeng Zang,et al.  Standardizing the intrinsic brain: Towards robust measurement of inter-individual variation in 1000 functional connectomes , 2013, NeuroImage.

[12]  A. Belger,et al.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development , 2003, Psychopharmacology.

[13]  S. Kapur.  Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. , 2003, The American journal of psychiatry.

[14]  Xi-Nian Zuo,et al.  REST: A Toolkit for Resting-State Functional Magnetic Resonance Imaging Data Processing , 2011, PloS one.

[15]  C. Correll,et al.  Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. , 2003, The American journal of psychiatry.

[16]  J. Sweeney,et al.  Risperidone in first-episode psychosis: A longitudinal, exploratory voxel-based morphometric study , 2006, Schizophrenia Research.

[17]  M. Laruelle,et al.  Neurobiology of dopamine in schizophrenia. , 2007, International review of neurobiology.

[18]  D. Collier,et al.  Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study. , 2009, The American journal of psychiatry.

[19]  Chaogan Yan,et al.  DPARSF: A MATLAB Toolbox for “Pipeline” Data Analysis of Resting-State fMRI , 2010, Front. Syst. Neurosci..

[20]  A. Mechelli,et al.  Dysconnectivity in schizophrenia: Where are we now? , 2011, Neuroscience & Biobehavioral Reviews.

[21]  A. Vita,et al.  The effects of antipsychotic treatment on cerebral structure and function in schizophrenia , 2007, International review of psychiatry.

[22]  H. Hwu,et al.  Frequency‐specific alternations in the amplitude of low‐frequency fluctuations in schizophrenia , 2014, Human brain mapping.

[23]  Y. Zang,et al.  Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI , 2007, Brain and Development.

[24]  J. Sweeney,et al.  Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia , 2005, Biological Psychiatry.

[25]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[26]  Li Yao,et al.  Altered cortical thickness related to clinical severity but not the untreated disease duration in schizophrenia. , 2015, Schizophrenia bulletin.

[27]  Andreas Meyer-Lindenberg,et al.  From maps to mechanisms through neuroimaging of schizophrenia , 2010, Nature.

[28]  Mark Slifstein,et al.  The nature of dopamine dysfunction in schizophrenia and what this means for treatment. , 2012, Archives of general psychiatry.

[29]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[30]  Karen Faith Berman,et al.  Executive Function, Neural Circuitry, and Genetic Mechanisms in Schizophrenia , 2010, Neuropsychopharmacology.

[31]  X. Zuo,et al.  Test-retest reliabilities of resting-state FMRI measurements in human brain functional connectomics: A systems neuroscience perspective , 2014, Neuroscience & Biobehavioral Reviews.

[32]  Wei Deng,et al.  Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging. , 2010, Archives of general psychiatry.

[33]  J. Sweeney,et al.  An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia , 2009, Psychiatry Research: Neuroimaging.